Peter A. Schneider, MD, FACS

Original Contribution

Total IN.PACT All-Subjects One-Year Analysis and Standard vs Broader Implications

07/01/2020

Daniel S. Kobe , MD;

Mehdi H. Shishehbor , DO, MPH, PhD;

Peter A. Schneider , MD, FACS;

Thomas Zeller , MD, PhD;

Michael R. Jaff , MD, DO;

Drug-coated balloons (DCBs) have been shown to be superior to percutaneous transluminal angioplasty (PTA) for symptomatic femoropopliteal disease in randomized clinical trials; however, their clinical effectiveness and safety in more complex...

Drug-coated balloons (DCBs) have...

07/01/2020

Journal of Invasive Cardiology

Interim Results of the PROMISE I Trial to Investigate the LimFlow System of Percutaneous Deep Vein Arterialization for the Treatment of Critical Limb Ischemia

02/24/2019

Peter A. Schneider , MD, FACS;

Jihad A. Mustapha , MD, FACC, FSCAI;

Daniel G. Clair , MD;

Fadi Saab , MD, FACC, FSCAI;

Our objective was to investigate the efficacy and safety of LimFlow percutaneous deep vein arterialization device in no-option CLI patients.

Our objective was to investigate...

02/24/2019

Journal of Invasive Cardiology

Original Contribution

Cost-Effectiveness of Percutaneous Deep Vein Arterialization for Patients With No-Option Chronic Limb-Threatening Ischemia: An Exploratory Analysis Based on the PROMISE I Study

07/26/2021

Jan B. Pietzsch , PhD;

Merle Ederhof , PhD;

Benjamin P. Geisler , MD, MPH;

Peter A. Schneider , MD, FACS;

Our study objective was to explore the potential cost-effectiveness of treatment with the LimFlow pDVA system (LimFlow SA) in the United States healthcare system.

Our study objective was to...

07/26/2021

CardioVascular

Clinical Review

Explaining the Discrepancy Between Lower Patency and Higher Limb Salvage Rates After Revascularization for Critical Limb Ischemia

10/31/2016

Carly N. Richards , MD;

Peter A. Schneider , MD, FACS;

Limb salvage rates that are consistently superior to patency rates for CLI patients have prompted some to question whether perfusion really matters. The authors explore the discrepancy and find that the difference can be explained by several...

Limb salvage rates that are...

10/31/2016

Vascular Disease Management

ISET 2023

Intermediate-Term (24-Month) Results of the TRANSCEND Study: Comparing a Next-Generation Paclitaxel Drug-Coated Balloon (SurVeil DCB) to IN.PACT Admiral DCB in the Treatment of Femoropopliteal Artery Disease

01/17/2023

Kenneth Rosenfield , MD, MHCDS;

Amanda Wright Harvey ;

Peter A. Schneider , MD, FACS;

Marianne Brodmann , MD;

William A. Gray , MD, FACC, FSCAI;

In this session from Tuesday afternoon, Peter A. Schneider, MD, Marianne Brodmann, MD, William Gray, MD, and Kenneth Rosenfield, MD reported 24-month results from the TRANSCEND study, which compared the SurVeil drug-coated balloon (DCB) to...

In this session from Tuesday...

01/17/2023

Vascular Disease Management

LINC 2022

Exploring the Role of Transcarotid Artery Revascularization in Treating Carotid Stenosis

06/07/2022

Peter A. Schneider , MD, FACS;

Dr. Peter Schneider discusses his presentation on clinical insights on the use of transcarotid artery revascularisation (TCAR) for treating carotid artery stenosis at LINC 2022.

Dr. Peter Schneider discusses...

06/07/2022

Vascular Disease Management

VEITHSymposium: 1. The European History with BTK Lesions; 2. Decreasing Access Site Complications with Routine Ultrasound Guidance

01/31/2014

Peter A. Schneider , MD, FACS;

Many of the tools, ideas and approaches that we have now were first attempted and then further developed in Europe before transferring to other areas.

Many of the tools, ideas and...

01/31/2014

Cath Lab Digest